204 related articles for article (PubMed ID: 33583621)
1. A new medication, a new toxidrome - A case report of anticholinergic wipe toxicity due to improper medication use.
Michael T; Paul C
Am J Emerg Med; 2021 Aug; 46():797.e1-797.e2. PubMed ID: 33583621
[TBL] [Abstract][Full Text] [Related]
2. Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis.
Pariser DM; Lain EL; Mamelok RD; Drew J; Mould DR
Clin Pharmacokinet; 2021 May; 60(5):665-676. PubMed ID: 33433785
[TBL] [Abstract][Full Text] [Related]
3. A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.
Glaser DA; Hebert AA; Nast A; Werschler WP; Green L; Mamelok RD; Quiring J; Drew J; Pariser DM
Am J Clin Dermatol; 2019 Aug; 20(4):593-604. PubMed ID: 31111409
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic mydriasis in an infant following parental use of topical glycopyrronium tosylate.
Seto S; Teo AA; Walsh RD
J AAPOS; 2019 Dec; 23(6):359-361. PubMed ID: 31683011
[TBL] [Abstract][Full Text] [Related]
5. Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis.
Nwannunu CE; Limmer AL; Coleman K; Shah R; Patel RR; Mui UN; Tyring SK
Skin Therapy Lett; 2019 Mar; 24(2):1-3. PubMed ID: 30970203
[TBL] [Abstract][Full Text] [Related]
6. Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials.
Glaser DA; Hebert AA; Nast A; Werschler WP; Green L; Mamelok R; Drew J; Quiring J; Pariser DM
J Am Acad Dermatol; 2019 Jan; 80(1):128-138.e2. PubMed ID: 30003988
[TBL] [Abstract][Full Text] [Related]
7. Qbrexza - A glycopyrronium cloth for axillary hyperhidrosis.
Med Lett Drugs Ther; 2019 Jan; 61(1564):10-11. PubMed ID: 30856158
[No Abstract] [Full Text] [Related]
8. Urinary retention and mydriasis secondary to topical glycopyrronium for axillary hyperhidrosis.
Green HH; Ray L; Buchanan J; Matsler N
Am J Health Syst Pharm; 2023 Sep; 80(18):1234-1237. PubMed ID: 37348110
[TBL] [Abstract][Full Text] [Related]
9. Glycopyrronium (Qbrexza) Topical Wipes for Hyperhidrosis.
Arnold MJ; O'Connor C
Am Fam Physician; 2019 Sep; 100(6):372-373. PubMed ID: 31524358
[No Abstract] [Full Text] [Related]
10. Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension study.
Hebert AA; Glaser DA; Green L; Hull C; Cather J; Drew J; Gopalan R; Pariser DM
Pediatr Dermatol; 2020 May; 37(3):490-497. PubMed ID: 32147881
[TBL] [Abstract][Full Text] [Related]
11. Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its Use.
Lamb YN
Clin Drug Investig; 2019 Nov; 39(11):1141-1147. PubMed ID: 31571127
[TBL] [Abstract][Full Text] [Related]
12. Variables Affecting Delivery of Glycopyrronium Tosylate Through Human Skin In Vitro.
Caserta F; Lenn J; Hofland H
J Drugs Dermatol; 2020 Nov; 19(11):1080-1085. PubMed ID: 33196749
[TBL] [Abstract][Full Text] [Related]
13. Use of gloves when applying topical glycopyrronium for treatment of primary axillary hyperhidrosis.
Siscos SM; Figenshau K; Rajpara A
J Am Acad Dermatol; 2020 Oct; 83(4):e275. PubMed ID: 31846717
[No Abstract] [Full Text] [Related]
14. Use of oral glycopyrronium bromide in hyperhidrosis.
Bajaj V; Langtry JA
Br J Dermatol; 2007 Jul; 157(1):118-21. PubMed ID: 17459043
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic Mydriasis Secondary to Topical Glycopyrronium Tosylate Cloths: Clinical Characterization From a Multicenter Analysis.
Kaufman AR; Gulati S; Pula JH; Janetos TM; Cherayil NR; Chiu E; Shepherd EA; Golnik KC; Garcia-Valenzuela E; MacIntosh PW; Johnson BT; Curnyn KM
J Neuroophthalmol; 2022 Dec; 42(4):530-534. PubMed ID: 35427257
[TBL] [Abstract][Full Text] [Related]
16. Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis: A randomized, double-blind, vehicle-controlled study.
Yokozeki H; Fujimoto T; Wanatabe S; Ogawa S; Fujii C
J Dermatol; 2022 Jan; 49(1):86-94. PubMed ID: 34636057
[TBL] [Abstract][Full Text] [Related]
17. Mydriasis and anisocoria in a pediatric hyperhidrosis patient with interesting findings in the family cat.
Sandhu M; Eisenstein K
Pediatr Dermatol; 2023 Jan; 40(1):210-211. PubMed ID: 36263444
[TBL] [Abstract][Full Text] [Related]
18. Treatment of compensatory gustatory hyperhidrosis with topical glycopyrrolate.
Kim WO; Kil HK; Yoon DM; Cho MJ
Yonsei Med J; 2003 Aug; 44(4):579-82. PubMed ID: 12950111
[TBL] [Abstract][Full Text] [Related]
19. Anisocoria secondary to antiperspirant wipes in a pediatric population: a case series.
Pecha JD; Yen KG; Moisiuc A; Cantor A
J AAPOS; 2022 Feb; 26(1):42-43. PubMed ID: 34798293
[TBL] [Abstract][Full Text] [Related]
20. Reversible anisocoria due to inadvertent ocular exposure to topical anticholinergic treatment for primary axillary hyperhidrosis.
Pashaei-Marandi A; Assam JH; Arnold A; Lee AG; Bonelli L
Can J Ophthalmol; 2019 Dec; 54(6):e300-e302. PubMed ID: 31836120
[No Abstract] [Full Text] [Related]
[Next] [New Search]
